ATE282632T1 - Neuropeptid y agonisten - Google Patents

Neuropeptid y agonisten

Info

Publication number
ATE282632T1
ATE282632T1 AT97923672T AT97923672T ATE282632T1 AT E282632 T1 ATE282632 T1 AT E282632T1 AT 97923672 T AT97923672 T AT 97923672T AT 97923672 T AT97923672 T AT 97923672T AT E282632 T1 ATE282632 T1 AT E282632T1
Authority
AT
Austria
Prior art keywords
neuropeptide
agonists
ligands
npy24
predisposing
Prior art date
Application number
AT97923672T
Other languages
English (en)
Inventor
Erica Potter
Original Assignee
Prince Of Wales Medical Res In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prince Of Wales Medical Res In filed Critical Prince Of Wales Medical Res In
Application granted granted Critical
Publication of ATE282632T1 publication Critical patent/ATE282632T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57545—Neuropeptide Y
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97923672T 1996-06-05 1997-06-05 Neuropeptid y agonisten ATE282632T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO0290A AUPO029096A0 (en) 1996-06-05 1996-06-05 Npy y2 agonists
PCT/AU1997/000352 WO1997046579A1 (en) 1996-06-05 1997-06-05 Neuropeptide y agonists

Publications (1)

Publication Number Publication Date
ATE282632T1 true ATE282632T1 (de) 2004-12-15

Family

ID=3794609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923672T ATE282632T1 (de) 1996-06-05 1997-06-05 Neuropeptid y agonisten

Country Status (8)

Country Link
EP (1) EP0907658B1 (de)
JP (1) JP2001508025A (de)
CN (1) CN1322212A (de)
AT (1) ATE282632T1 (de)
AU (1) AUPO029096A0 (de)
CA (1) CA2257424A1 (de)
DE (1) DE69731635T2 (de)
WO (1) WO1997046579A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
NZ532427A (en) 2001-09-24 2008-07-31 Imp Innovations Ltd Modification of feeding behavior using PYY (peptide YY) and its agonists such as NPY (neuropeptide Y)
CA2461454A1 (en) 2001-09-24 2003-04-03 Oregon Health And Science University Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
ATE549350T1 (de) 2005-12-07 2012-03-15 Hoffmann La Roche Neuropeptid-2-rezeptor-agonisten
TWI428346B (zh) 2006-12-13 2014-03-01 Imp Innovations Ltd 新穎化合物及其等對進食行為影響
DK2983690T3 (da) * 2013-04-10 2019-05-20 Univ Copenhagen Neuropeptid Y-afledte peptider

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811193A1 (de) * 1988-04-01 1989-10-19 Boehringer Ingelheim Kg Neue peptide, verfahren zu ihrer herstellung und diese peptide enthaltende pharmazeutische zusammensetzungen
EP0692971A4 (de) * 1993-03-29 1997-11-12 Univ Cincinnati Peptid yy-analogen und verwendungen dafür
CA2134428A1 (en) * 1994-10-26 1996-04-27 Albert Tseng Neuropeptide y y2 agonist peptides

Also Published As

Publication number Publication date
EP0907658A1 (de) 1999-04-14
JP2001508025A (ja) 2001-06-19
CN1322212A (zh) 2001-11-14
DE69731635D1 (en) 2004-12-23
AUPO029096A0 (en) 1996-07-04
EP0907658A4 (de) 2001-09-05
EP0907658B1 (de) 2004-11-17
CA2257424A1 (en) 1997-12-11
WO1997046579A1 (en) 1997-12-11
DE69731635T2 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
DK0912176T3 (da) Anvendelse af pyridylalkan-, pyridylalken- og/eller pyridylalkynsyreamider til behandling af tumorer eller immunosuppression
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
TR199902082T2 (xx) Pirazin bile�ikleri.
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
EA200001037A1 (ru) Легочная и назальная доставка ралоксифена
EA200200208A1 (ru) Синергитическая композиция
DK1135153T3 (da) Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser
ATE247470T1 (de) Neue substituierte imidazolverbindungen
FI964004A (fi) Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
GB9818916D0 (en) Use
ATE243993T1 (de) Verwendung von 5ht3 antagonisten zum fördern der darmspülung
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
DE69915310D1 (de) Methoden zur behandlung der salzabhängigen hypertonie
ATE348812T1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
DK1032414T3 (da) Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
ATE282632T1 (de) Neuropeptid y agonisten
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DE69810513D1 (de) Mimetika von beta-faltblatt und verfahren zur verwendung davon
DE60040089D1 (de) Menschliches homolog aus der familie der metalloproteasen
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
NO986189D0 (no) FremgangsmÕte for inhibering av avleiring av organiske forurensninger i sys
ATE335496T1 (de) Angiotensin ii und analoga zur begrenzung von narben und adhäsionbildung
EA199800889A1 (ru) Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties